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SUMMARY 
Background: To determine the prevalence of diabetic retinopathy maculopathy and cataract amongst diabetics and 
the prevalence of visual impairment amongst diabetics attending the Komfo Anokye Teaching Hospital eye unit. 
There are no current data in the study area on the prevalence of visual impairment and blindness amongst diabetics. 
This data is required in planning for screening and prevention of blindness due to diabetics.  
Methods: This was a hospital based cross sectional study. Subjects were diabetic patients attending the diabetic 
clinic. Simple random sampling was used. Demographic was taken. Visual acuity and refraction was done. Slit lamp 
examination was used to identify cataract. Maculopathy and retinopathy was determined using a 90D Volk lens and 
an indirect ophthalmoscope. 
Results: Non -insulin dependent diabetics constituted 97.1% whilst 2.9% were insulin dependent diabetics. The 
prevalence of the outcomes measures was: Cataract (23.7%) mild and moderate retinopathy (13.7%) severe prolifer-
ative retinopathy (1.8%) maculopathy (6.8%).  Prevalence of low vision and blindness was 18.4%. Amongst diabet-
ics 59.1% had no previous eye evaluation. Impaired vision due to cataract was 24.0 % representing a 40% decline in 
a decade. 
Conclusion: The prevalence of visual impairment was high at 18.4%. The reduction in impaired vision due to cata-
ract over a decade is suggestive of either an improved cataract surgical rate or improved diabetic care or both. Ma-
jority of the diabetic patients 59.1% had not received prior ocular evaluation. There is an urgent need to have a 
screening program in this area 
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INTRODUCTION 
Loss of vision is one of the many long-term complica-
tions of diabetes mellitus. Globally, diabetes is one of 
the leading causes of blindness amongst the working 
population. In 2011 the total number of people with 
diabetes was estimated to be 366 million globally. This 
is estimated to rise to 552 million by 2030 as a result of 
rapid demographic transition due to urbanization, life-
style changes and an ageing population. Nearly 80% of 
this number is said to be in middle and lower income 
countries.1 Between 2010 and 2030, there will be a pro-
jected 69% increase in the numbers of adults with dia-
betes in developing countries.2 Met-analysis of the 
overall global prevalence of Diabetic Retinopathy (DR) 
from a total of 35 studies (1980–2008) was 34.6% for 
any Diabetic Retinopathy, 6.96% for proliferative Dia-
betic Retinopathy, 6.81% for Diabetic Macular Oedema, 
and 10.2% for vision-threatening Diabetic Retinopathy.3  
 
An analysis by Burgess et al of sixty-two studies from 
21 African countries showed prevalence of diabetic ret-
inopathy ranged from 30.2 to 31.6%, proliferative dia-
betic retinopathy 0.9 to 1.3%, and any maculopathy 1.2 
to 4.5% in population-based studies. In clinic-based 
surveys, the reported prevalence ranged from 7.0 to 
62.4%, proliferative diabetic retinopathy 0 to 6.9%, and 
any maculopathy 1.2 to 31.1%.4 In Ghana and Nigeria 
the prevalence of all diabetic retinopathy was 17.7%.5 
 
Loss of vision in diabetics is due mainly to retinopathy 
including maculopathy. Retinopathy progresses from a 
latent asymptomatic stage to a visually symptomatic 
stage. Apart from diabetic retinopathy, cataract due to 
the osmotic changes in uncontrolled diabetics is com-
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Legal blindness (best corrected visual acuity of 6/60 or 
worse in the best eye) is found to be twenty-five times 
more common in the diabetic population than in those 
without the disease.6,7    
 
Therefore, early and regular screening of all diabetic 
patients is required to prevent blindness in an already 
disabling disease. The objective of this study was to 
determine the prevalence of retinopathy and cataract 
and to determine the prevalence of visual impairment 
and legal blindness among diabetic patients attending 
the Out-Patient Department (OPD) clinic at a Teaching 
Hospital in the northern sector of Ghana. There are no 
data existing in this area on the prevalence of visual 
impairment and legal blindness from diabetics. There is 
no formal screening program in place in this region for 
identifying diabetics at risk of blindness. The data will 
help in the planning for a screening program for diabetic 




This is a hospital based cross sectional study involving 
the adult population of diabetics over a period of three 
months in the year 2012. The study sites were the Dia-
betic Center and the Eye Department of a tertiary teach-
ing hospital in the Ashanti region of Ghana. The study 
participants were patients with confirmed diagnosis of 
diabetes who attend the diabetic clinic. Patients were 
selected by simple random sampling (SRS) technique. 
Using a 25% probability of being selected and computer 
generated random numbers. An informed written con-
sent was obtained from each patient. Ethical clearance 
was sought from the Committee on Human Research, 
Publications and Ethics, Kwame Nkrumah University of 
Science and Technology, School of Medical Sciences 
and Research and Development Unit of Komfo Anokye 
Teaching Hospital. 
 
The inclusion criteria were confirmed diagnosis of dia-
betes and patients 18 years and above. The exclusion 
criteria were patients with gestational diabetes, sickle 
cell disease, hypertensive and coexisting ocular pathol-
ogy apart from cataract. Any type of visible lens opaci-
ties unilateral or bilateral, was noted by the same exam-
iner. Coexisting ocular morbidity with likely secondary 
cataract were excluded. 
 
Using a structured questionnaire, data on age, gender, 
profession, duration of diabetes was obtained. Type of 
diabetes and treatment type were also obtained from the 
record of the participants. The visual acuity and pin hole 
testing with Snellen acuity chart was done. Refraction 
was done. The anterior segment of the eyes was exam-
ined with a slit lamp bio-microscope.  
The pupils were then dilated with topical 2% tropi-
camide and 2.5% phenylephrine and fundus examina-
tion was done with a 90D Volk lens on a slit lamp, and a 
Heine indirect ophthalmoscope with 20D Volk lens by 
the same person. Retinopathy and maculopathy were 
then determined and graded using the early treatment 
diabetic retinopathy study (EDTRS) protocol. Partici-
pants found to have proliferative retinopathy and/or 
macular oedema were offered laser treatment or anti 
Vascular Endothelial Growth Factor injection or both.  
 
Data analysis 
Rates and means were determined and a confidence 
interval of 95% was used. The results of prevalence of 
cataract from this study was then compared with a simi-
lar study by Rotimi et al in the same study area and 
study site a decade ago with similar population to de-
termine the change in prevalence of cataract amongst 
diabetics in the area in 10 years. In this study, when 
both eyes had retinopathy, data from the eye with the 
worse retinopathy was used for the analysis. The eye 
with the better visual acuity after best corrected vision 
was used for the analysis of visual acuities. Low vision 
was defined as visual acuity of less than or equal to 6/18 
in the better eye after best corrected vision. Blindness 
was defined using the legal blindness criteria of visual 




A total of 208 patients participated in the study The 
mean age (± SD) was 57.5 ± 13 years. There were more 
females (70.7%) than males. More than half of the par-
ticipants (59.1%) had not been examined   by an oph-
thalmologist ever since they were diagnosed with diabe-
tes mellitus. Of those whose eyes have been examined 
before, 83.5% of them had their eyes examined within 
the last 5 years ago 2.4% had not been examined. (Table 
1).  
 
Table 1 Demographics and ocular examination  
 N=208 Frequency Percent (%) 
Age(years) Mean (SD)=57.5(13.0) 
Age category (years)   
19-38 17 8.2 
39-58 94 45.5 
59-78 83 39.9 
>78 14 6.7 
Gender   
Male 61 29.3 
Female 147 70.7 
Yes 85 40.9 
No 123 59.1 
Last time eyes examined, N= 85 
Less than 5 years 71 83.5 
5-10 years 12 14.1 
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There was 12.6% of the patients with low vision and 
5.8% were legally blind (Table 2). 
 




6/4 40 19.2 
6/5 34 16.4 
6/6 71 34.1 
6/9 31 14.9 
6/12 6 2.9 
6/18 8 3.9 
6/24 4 1.9 
6/36 2 1.0 
6/60 7 3.4 
CF 3 1.4 
HM 2 1.0 
 
Of the eyes examined 23.7% had cataracts (Table 3), 
Prevalence of any retinopathy was 15.5% and preva-
lence of maculopathy was 6.8% (Table 4). Impaired 
vision due to cataract was 24 %. Compared to a previ-
ous study in the same area by Rotimi et al in 2003 
(40%), impaired vision due to cataract had reduced by 
40 % in a decade.5 
 
Table 3 Distribution of lens characteristics 
Factor, N=412 Frequency Percentage (%) 
Lens   
Clear 304 73.8 
Cataract 99 24.0 
Pseudophakia 9 2.2 
 
Table 4 Prevalence of diabetic retinopathy and macu-
lopathy 
Prevalence of Retinopathy  
and Maculopathy, N=395 
Frequency Percentage 
(%) 
Retinopathy   
No Retinopathy 334 84.6 
Mild & moderate Retinopathy 54 13.7 
Proliferative 7 1.8 
Maculopathy   
No Maculopathy 368 93.2 
Maculopathy 27 6.8 
 
DISCUSSION 
The prevalence of any diabetic retinopathy was 15.5%. 
This has not changed much in nearly a decade and a half 
since 2003 when a similar study conducted in the same 
area by Rotimi et al found a prevalence of 17.9%.5 This 
is lower than the estimated global prevalence of 34.6% 
for all retinopathy.3 But within the ranges of the preva-
lence of any retinopathy of 7-62.4%4 for clinic-based 
studies in Africa and population-based studies of any 
retinopathy of 9.2%8, 37.5%8, 15%10 and 23%.11  
 
The prevalence of proliferative retinopathy of 1.8% in 
this study is much lower than the global proliferative 
diabetic retinopathy prevalence of 6.9%.3  
However, the prevalence of proliferative retinopathy 
demonstrated by this study compares similarly with the 
prevalence of 0-6.9% for clinic-based studies in Africa. 
4 In this study, the prevalence of legal blindness was 
5.8% and of all visual impairment was 12.6 %. More 
than half (59.1%) of participants had not had an eyes 
evaluation ever since they were diagnosed with diabetes 
mellitus. This was higher than in Ethiopia where 42.9% 
of diabetics had been screened for Diabetes retinopa-
thy.12  
 
This represents a significant number of diabetics who 
are not getting an eye evaluation thus increasing their 
risk for losing their vision. About a quarter (24.0 %) of 
the eyes examined had cataracts. This value is higher 
than that found in an African study by Eugene Sobngwi 
and colleagues (14.38%).9 It is lower than that found by 
Mash and colleagues in their study (35.2%).13 It is lower 
than a study in the same study area by Rotimi et al .5 
 
They found that 40 % of diabetics had visually impair-
ing cataract5. This seems to suggest that there has been a 
reduction of 42% in 10 years in the prevalence of visu-
ally impairing cataracts amongst diabetics in the same 
area. Over this period the cataract surgical rate in Ghana 
has improved from 300 to 900. This could explain the 
reduced prevalence of cataract amongst diabetics. It 
may also be an indication of better sugar control in dia-
betics in the study area.  
  
The limitations of this study are that since it is a hospi-
tal-based study the results cannot be applied to the gen-
eral population. The fact that the retinal findings were 
not cross checked by another retinal specialist may also 
lead to under and over diagnosis of retinopathy. Ocular 
coherence tomography (OCT) was not used to evaluate 
the maculopathy in this study, as it was not available in 
the study area at the time of the study. As such the as-
sessment of maculopathy was only based on qualitative 
clinical judgement.   
 
CONCLUSION 
In the hospital setting of this region of Ghana, 18.4 % of 
all diabetics attending the clinic have impaired vision of 
which 5.8% are legally blind. More than half (59.1%) 
have not been screened for diabetic retinopathy. Since 
diabetics are already a very debilitating disease, any 
further visual disabilities in addition to the numerous 
other disabilities greatly reduce the quality of life and 
life expectancy. There is an urgent need to have an ef-
fective screening program to prevent diabetics from 






                                                                                                                                                                               
www.ghanamedj.org  Volume 52 Number 2 June 2018 87 
REFERENCES 
1. Godfrey R, Julien M. Urbanisation and health. Clin 
Med.  2005; 5:137–141. 
2. Shaw JE, Sicree RA, Zimmet P Z. Global esti-
mates of the prevalence of diabetes for 2010 and 
2030. Diabetes Res Clin Pract. 2010; 87(1) :4–14.  
3. Yau JW, Rogers SL, Kawasaki R , Lamoureus EL, 
Kowalski JL ,Bek T et al.  Global prevalence and 
major risk factors of diabetic retinopathy. Diabetes 
Care. 2012; 35(3): 556–564. 
4. Burgess PI, MacCormick IJ, Harding SP, Basta-
wrous A, Beare NE, Garner P. Epidemiology of 
diabetic retinopathy and maculopathy in Africa: a 
systematic review. Diabet Med. 2013; Apr, 30 (4) 
: 399-412. doi:10.1111/j.1464-5491.2012.03756.x.  
5. Rotimi C, Daniel H, Zhou J, Obisesan A, Chen G, 
Amoah A et al. Prevalence and determinants of 
diabetic retinopathy and cataracts in West African 
type 2 diabetes patients. Ethn Dis. 2003; (2 suppl 
2):S110–117. 
6. Danquah I, Bedu-Addo G, Terpe K, Micah F, 
Amoako YA , Awuku YA . Diabetes mellitus type 
2 in urban Ghana: characteristics and associated 
factors. BMC Public Health .2012 Mar 20 ; (12) 
210: doi: 10.1186/1471-2458-12-210 
7. Amoah AG , Owusu SK, Schuster DP, Osei K. 
Pathogenic mechanism of type 2 diabetes in Gha-
naians--the importance of beta cell secretion, insu-
lin sensitivity and glucose effectiveness. S. Afr. 
Med. J. 2002 May; 92(5):  377–384. 
8. Mengesha AY, Spectrum of eye disorders among 
diabetes mellitus patients in Gaborone, Botswana. 
Trop Doct .2006 Apr; 36(2): 109–111. 
9. Sobngwi E, Mbanya JC, Moukouri EN, Ngu KB . 
Microalbuminuria and retinopathy in a diabetic 
population of Cameroon. Diabetes Res. Clin. 
Pract. 1999 Jun; 44(3):191–196. 
10. Omolase CO, Adekanle O, Owoeye JF, Omolase 
BO. Diabetic retinopathy in a Nigerian communi-
ty. Singapore Med J. 2010 Jan; 51(1): 56–59. 
11. Unuigbe EI, Omeife H, Edema T, Ukoli FA. Mi-
croalbuminuria and associated factors in newly di-
agnosed diabetics. Niger Postgrad Med J .2001 
Dec; 8(4):187–192. 
12. Gudina EK, Amade ST, Tesfamichael FA, Ram R 
. Assessment of quality of care given to diabetic 
patients at Jimma University Specialized Hospital 
diabetes follow-up clinic, Jimma, Ethiopia. BMC 
Endocr Disord 2011 11, 19. doi: 10.1186/1472-
6823-11-19.  
13. Mash B, Powell D, du Plassis F, van Vuuren U, 
Michalowska M, Levitt N  . Screening for diabetic 
retinopathy in primary care with a mobile fundal 
camera--evaluation of a South African pilot pro-
ject. S. Afr. Med. J. 2007; 97(12):1284–1288. ✪ 
  
 
 
